Latest News - Hyperhidrosis

Tuesday, July 09, 2019 | Personnel/Company News, Product Launches and Updates, Hyperhidrosis

Proof of Concept Study Supports Dermata’s Topical Delivery Mechanism for Botulinum Toxin

Dermata Therapeutics’ DMT410 (DMT310 + botulinum toxin) performed well in a Phase 1proof of concept study for the treatment of primary axillary hyperhidrosis, the Company reports. DMT410…

Read the full story